DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20212819

Risk of bleeding after plasmapheresis!

Asmaa K. Ahmed, Magdy M. El-Sharkawy, Mahmoud R. Mohamed

Abstract


Background: Plasmapheresis is a growing up method used for treatment of many diseases. it is considered as first line therapy for different diseases. During this therapeutic modalities there is an undesirable l removal of coagulation proteins particularly fibrinogen. Aim The aim of the present study was to assess the presence or absence of bleeding risk following therapeutic plasmapheresis. This was done by assessment of fibrinogen level pre and post plasmpharesis in different indication including the renal and non-renal disorders.

Methods: The present case control study was conducted on 40 persons from El-Demerdash Hospital in Ain Shams University from the period of May 2019 till November 2019. The study was approved by the hospital’s research ethics board. The 40 patients were divided into 2 groups according to presence or absence of renal disoredes as renal and non-renal indication for plasmapheresis, Fibrinogen level, aPTT, INR were estimated pre and post session of plasmapheresis. Also, all patients were observed during plasmapheresis session and for 72 hours later for clinical evidence of bleeding tendency.

Results: Fibrinogen levels and aPTT were reduced significantly following plasmapharesis but without increased risk of bleeding.

Conclusions: Fibrinogen level should be assessed in patients undergoing plasmapheresis especially those indicated for invasive maneuvers or surgery following plasmapheresis.

 


Keywords


Plasmapheresis, Fibrinogen, aPTT, Bleeding risk

Full Text:

PDF

References


Schwartz J1, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue, J. Clin. Apheresis. 2016;31:149-62.

Malchesky PS. Therapeutic Apheresis: Why? Ther Apher Dial.2015;19(5):417-26.

Pham HP, Schwartz J, Cooling L, Hofmann JC, Kim HC, Morgan S, et al. Report of the ASFA apheresis registry study on Wilson's disease. J Clin Apher. 2016;31(1):11-5.

McLeod BC. Therapeutic apheresis: use of human serum albumin, fresh frozen plasma and cryosupernatant plasma in therapeutic plasma exchange. Best Pract Res Clin Haematol. 2006;19(1):157-67.

Kaplan AA. Therapeutic plasma exchange: A technical and operational review. J Clin Apher. 2013;28:3-10.

Angela M, CarterKristina F, J SP, Grant, Emery, Rimoin's. Principles and Practice of Medical Genetics. 2013.

Zöllner S, Pablik E, Druml W, Derfler K, Rees A, Biesenbach P. Fibrinogen reduction and bleeding complications in plasma exchange, immunoadsorption and a combination of the two. Blood Purif. 2014;38(2):160-6.

Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue. J Clin Apher. 2019;34(3):171-354.

Roman PE, DeVore AD, Welsby IJ. Techniques and applications of perioperative therapeutic plasma exchange. Current opinion in anaesthesiology. 2014;27:57-64.

Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J Clin Apher. 2016;31(3):149-62.

Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB. Epidemiology of autoimmune diseases in Denmark. J Autoimmun. 2007;29(1):1-9.

Hasan Z, Al-Niami M, AL-Shammari H. Glimpse on Hemostatic Changes Produced By Plasmapheresis. J Fac Med Bagdad. 2010.

Sharma G, Sood S, Sharma S. Seasonal, Age & Gender Variation of Guillain Barre Syndrome in a Tertiary Referral Center in India. Neuroscience and Medicine. 2013;4:23-8.

Thölking G, Mesters R, Dittrich R, Pavenstädt H, Kümpers P, Reuter S. Assessment of Hemostasis after Plasma Exchange Using Rotational Thrombelastometry (ROTEM). PLoS One. 2015;10(6):e0130402.

pagana KD, Pagana TJ, Pagana TN. Mosby’s Diagnostic & Laboratory Test Reference. 14th ed. St. Louis, Mo: Elsevier. 2019.

Domen R, Kennedy M, Jones L, Senhauser D. Hemostatic imbalances produced by plasma exchange. Transfusion. 1984,24:336-9.